tiprankstipranks

Steven Gillis Insider Profile

11 Followers
Steven Gillis, Director at Bluebird Bio, holds 1.05M shares in VBI Vaccines (Ticker: VBIVQ), holds 8.75K shares in Codiak BioSciences (Ticker: CDAKQ), holds 3.44M shares in Pulmatrix (Ticker: PULM). Most recently, Steven Gillis Bought ― shares of VBI Vaccines on Jul 18, 2023 for an estimated value of 1.00M.
tipranks
Steven Gillis

Steven Gillis
Bluebird Bio (BLUE)
Director

Ranked #60,877 out of 99,335 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

-5.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$185M
88.64%
11.34%
0.02%
<0.01%
A breakdown of Steven Gillis's holdings

Insider Roles

Q32 Bio
(QTTB)
Director
Pulmatrix
(PULM)
Director
Bluebird Bio
(BLUE)
Director
VBI Vaccines
(VBIVQ)
Director
Roles that Steven Gillis holds in companies

Most Profitable Insider Trade

Stock:
VBI Vaccines
(VBIVQ)
Rating:Informative Buy
Date:Sep 23, 2019 - Sep 23, 2020
Return:+487.00%
The most profitable trade made by Steven Gillis

Steven Gillis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bluebird Bio
Jul 30, 2015
Director
Uninformative Buy
$32.46K
Q32 Bio
Apr 04, 2018
Director
Uninformative Buy
$164.10M
Pulmatrix
Apr 05, 2018
Director
Uninformative Buy
$21.00M
CDAKQ
Codiak BioSciences
Sep 15, 2022
Uninformative Buy
$96.25
VBI Vaccines
Jul 18, 2023
Director
Informative Buy
1.00M
$10.46K
List of latest transactions for each holding click on a transaction to see Steven Gillis's performance on stock

Steven Gillis insider profile FAQ

What is the percentage of profitable transactions made by Steven Gillis?
The percentage of profitable transactions made by Steven Gillis is 43%.
    What is the average return per transaction made by Steven Gillis?
    The average return per transaction made by Steven Gillis is -5.40%.
      What stocks does Steven Gillis hold?
      Steven Gillis holds: BLUE, QTTB, PULM, CDAKQ, VBIVQ stocks.
        What was Steven Gillis’s latest transaction?
        Steven Gillis latest transaction was an Informative Buy of $1.00M.
          What was Steven Gillis's most profitable transaction?
          Steven Gillis’s most profitable transaction was an Informative Buy of VBIVQ stock on September 23, 2019. The return on the trade was 487.00%.
            What is Steven Gillis's role in Bluebird Bio?
            Steven Gillis's role in Bluebird Bio is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.